Injectable manufacturing — India's growing injectable CDMO
Biodeal operates a dedicated Injectable CDMO from its Paonta Sahib, Himachal Pradesh facility — purpose-built for sterile injectable manufacturing with validated Grade A/B clean rooms, aseptic filling lines for vials and ampoules, and lyophilisation capabilities.
Aseptic fill-finish
Grade A/B clean rooms
One of the most demanding segments in pharma
Injectable manufacturing is one of the most technically demanding segments of pharmaceutical production — it requires aseptic processing, validated clean room environments, sterile fill-finish capabilities and rigorous quality oversight at every step. Few Indian CDMOs are equipped to serve it at scale.
Backed by Piramal Alternatives' investment, Biodeal is scaling this capability to meet growing domestic and international demand. The Paonta Sahib facility is purpose-built for the work — housing validated Grade A/B clean rooms, aseptic filling lines for vials and ampoules, and lyophilisation for temperature- and moisture-sensitive molecules.
Aseptic by design
Drug and container sterilised separately, then assembled in a Grade A/B clean room.
Purpose-built
A dedicated Paonta Sahib facility engineered for sterile injectable production.
Scaling up
Piramal-backed investment expanding capacity for domestic and export demand.
Sterile formats, one specialist facility
From small volume parenterals to freeze-dried injectables — manufactured aseptically under validated Grade A/B clean room conditions, with full sterile processing in-house. Many of these formats are available as injectable products.
Small Volume Parenterals (SVP)
Vials and ampoules — antibiotics, vitamins, hormones and specialty injectables. Aseptic fill-finish under Grade A/B conditions.
Lyophilised Injectables
Freeze-dried injectable products for temperature-sensitive and moisture-sensitive pharmaceutical molecules.
Sterile Manufacturing
Full sterile processing — autoclave sterilisation, dry heat sterilisation and sterile filtration.
Vials & Ampoules
Glass vials in Type I borosilicate and ampoules across multiple fill volumes.
Large Volume Parenterals (LVP)
Large-volume parenteral solutions manufactured under controlled sterile conditions for hospital and clinical use.
Pre-Filled Syringes (PFS)
End-to-end aseptic fill-finish solutions for pre-filled syringes, supporting enhanced sterility assurance and patient convenience.
A sterile regime regulated markets can file against
Aseptic processing is unforgiving — so the Paonta Sahib facility pairs validated Grade A/B clean rooms with the quality discipline clients need to file confidently in regulated destination markets.
Grade A/B clean rooms
Validated clean room environments engineered for aseptic filling of vials and ampoules under contamination-controlled conditions.
Aseptic processing
Drug and container sterilised separately and assembled aseptically — for molecules that cannot be terminally sterilised.
WHO-GMP oversight
Sterile filtration, autoclave and dry heat sterilisation, with rigorous quality oversight and documentation on every batch.
Injectable manufacturing, answered
The questions brands ask most often when choosing an injectable CDMO partner.
Does Biodeal manufacture injectable pharmaceutical products?
Yes. Biodeal operates a dedicated injectable manufacturing facility at Paonta Sahib, Himachal Pradesh — with SVP, lyophilised injectables, aseptic fill-finish for vials and ampoules, and sterile manufacturing under validated clean room conditions.
What is aseptic manufacturing in pharmaceuticals?
Aseptic manufacturing is a production method for sterile pharmaceutical products where the drug and its container are sterilised separately and assembled in a Grade A/B clean room environment. It is used when the final product cannot be terminally sterilised.
What types of injectable products does Biodeal manufacture?
Biodeal manufactures Small Volume Parenterals (SVP) including vials and ampoules, lyophilised injectables, and sterile fill-finish products under WHO-GMP conditions at the Paonta Sahib facility.
Request injectable manufacturing capacity
Tell us your molecule, format and target markets — our injectable CDMO team responds with capacity availability and a preliminary manufacturing proposal within 48 hours. Facility visits to Paonta Sahib by appointment.
Tell us what you need to make
A focused brief gets you a routed answer from the right team within one working day.